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(on the left elbow, Figure 1A–1D; on the right hand, 
1.1 cm × 0.9 cm). All these lesions were excised 
with free margins, and histopathologic results 
confirmed basal cell carcinoma, SCC in situ, and 
well-differentiated (G1) SCC. The lesions were 
located at sites exposed to ultraviolet radiation. 
In September 2018, another skin lesion devel-
oped, in the left shoulder area. The tumor grew 
rapidly, and in February 2019, it reached the size 
of 10 cm × 10 cm × 5 cm. It was surgically removed, 
and a histopathologic examination revealed a ker-
atoacanthoma (Figure 1A –1D). During the follow-
-up, the patient was in good general condition. 
As the patient was on triple immunosuppressive 
therapy, she was closely monitored for cancer, 
but no other proliferative lesions were revealed. 
We present a case of a 66 -year -old female smok-
er with terminal kidney failure since August 2014 
in the course of polycystic kidney disease, 4 years 
after kidney transplant (May 2015), and receiv-
ing triple -drug immunosuppression (tacrolimus 
+ glucocorticoid + mycophenolate mofetil). Ad-
ditionally, the patient had 5 metachronous skin 
cancers and concomitant primary pulmonary ad-
enocarcinoma. One year after the transplant sur-
gery, she developed a skin lesion on her right low-
er leg (irregular, beige -white, of 1.5 cm in diame-
ter), which was excised in July 2016. Histopatho-
logic examination confirmed cutaneous squamous 
cell carcinoma (SCC). Other clinically overt skin 
lesions appeared in August 2017 (on the right 
forearm, 2.4 cm × 1.5 cm) and July–August 2018 
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Figure 1 Keratoacanthoma: A – a crater ‑like growth pattern may be noted (arrows); hematoxylin and eosin staining, 
magnification ×100; B – endophytic proliferation of the squamous epithelium accompanied by fibrosis and chronic 
inflammatory infiltrate (arrows); hematoxylin and eosin staining, magnification ×400
CLiNiCAL iMAge Metachronous skin cancers and posttransplant solid tumor 71
reFereNCes
1 Mittal A, Colegio OR. Skin cancers in organ transplant recipients. Am 
J Transplant. 2017; 17: 2509‑2530. 
2 Oh CC, Hofbauer GFL, Serra AL, et al. Painful skin lesions and squamous 
cell carcinoma predict overall mortality risk in organ transplant recipients: 
a cohort study. Br J Dermatol. 2017; 176: 1179‑1186. 
3 Bouwes Bavinck JN, Harwood CA, Genders RE, et al. Pain identifies 
squamous cell carcinoma in organ transplant recipients: the SCOPE ‑ITSCC 
PAIN study. Am J Transplant. 2014; 14: 668‑676. 
4 Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma 
skin cancer in patients with a history of nonmelanoma skin cancer: a crit‑
ical review of the literature and meta ‑analysis. Arch Dermatol. 2000; 136: 
1524‑1530. 
5 Kang W, Sampaio MS, Huang E, Bunnapradist S. Association of pretrans‑
plant skin cancer with posttransplant malignancy, graft failure and death in kid‑
ney transplant recipients. Transplantation. 2017; 101: 1303‑1309. 
In early April 2019, the patient developed bron-
chitis followed by bronchopneumonia. As there 
was no improvement of pneumonia, a lung com-
puted tomography scan was performed, which re-
vealed numerous coin lesions in both lungs. Due 
to the advanced stage of the process, diagnostic 
procedures were limited to cytology of pleural flu-
id and talc pleurodesis. Histopathology revealed 
lung adenocarcinoma with the p40(–), TTF -1(+++) 
pattern. The patient died 2 weeks later due to re-
spiratory insufficiency.
Basal cell carcinoma, cutaneous SCC, and ker-
atoacanthoma are common nonmelanoma skin 
cancers. It was reported that immunosuppres-
sive agents used after an organ transplant re-
duce the antitumor effect of immune cells, thus 
increasing the risk of skin cancer, as compared 
with healthy population.1 Of note, the symptom 
of spontaneous pain or pain on touching, which 
is not common in the general population, is a sig-
nificant indicator of the invasive form of SCC.2,3 
In our case, a primary pulmonary adenocarcino-
ma developed in a smoking patient 4 years post-
transplant. The presence of a keratoacanthoma in 
transplant recipients should prompt physicians 
to perform cancer screening, because this tumor 
is associated with a higher risk of posttransplant 
malignancy and death.4,5
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Figure 1  
Keratoacanthoma: 
C – a very well 
differentiated squamous 
keratinizing epithelium 
(arrows) with mild nuclear 
atypia; hematoxylin and 
eosin staining, 
magnification ×200; 
D – original image of 
the lesion; elevated 
borders and a depressed 
center filled with keratin 
may be noted.
